Could a pill replace IV arsenic for leukemia patients?
NCT ID NCT07296445
First seen Jan 06, 2026 · Last updated May 10, 2026 · Updated 20 times
Summary
This study tests if an oral (pill) form of arsenic trioxide works as well as the standard IV version for people with a low-risk type of acute promyelocytic leukemia (APL). About 120 adults and teens who have finished their first round of treatment will be randomly assigned to receive either the pill or IV during later treatment rounds. The goal is to see if the pill is absorbed similarly, keeps cancer away, and is easier for patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE PROMYELOCYTIC LEUKEMIA (APL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.